Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients

1 Oct 2023

Abstract excerpt

Recent evidence revealed important interactions between clonal hematopoiesis (CH) and cellular therapies established for the treatment of hematologic malignancies. The impact of CH on safety, efficacy, and outcome of chimeric antigen receptor (CAR) T-cell therapy is currently under investigation. We analyzed 110 patients with relapsed/refractory B-cell non-Hodgkin lymphoma (n = 105) or acute lymphoblastic...

Topics

Join the communities discussing this publication.

CAR-T cell therapy research
Viral Infectious Diseases and Gene Expression in Insects
Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37799345
DOI: 10.1097/hs9.0000000000000957

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated PatientsPMID 37799345Read ↗

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapySemantic proximity Read ↗

CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopeniasSemantic proximity Read ↗

Implications of Clonal Hematopoiesis for Precision OncologySemantic proximity Read ↗

Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphomaSemantic proximity Read ↗

The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia.Semantic proximity Read ↗

Genomic correlates of clinical CAR-T cell activitySemantic proximity Read ↗

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years.Semantic proximity Read ↗

Distinct landscape and clinical implications of therapy-related clonal hematopoiesis.Semantic proximity Read ↗

Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias.Semantic proximity Read ↗

The crossroads of cancer therapies and clonal hematopoiesis.Semantic proximity Read ↗

TET2 Clonal Hematopoiesis Is Associated With Anthracycline-Induced Cardiotoxicity in Patients With LymphomaSemantic proximity Read ↗

High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.